MESALAZINE
Mesalazine is an anti-inflammatory drug used primarily in the treatment of inflammatory bowel disease (IBD) conditions such as ulcerative colitis and Crohn's disease. It works by reducing inflammation in the intestines.-Ulcerative Colitis -Crohn's Disease (in some cases) -Maintenance of remission in IBD
-Adult Dosage: Typically, 2.4 to 4.8 grams per day, divided into multiple doses. The exact dosage depends on the severity of the condition and the specific formulation used. -Pediatric Dosage: Dosage for children should be determined by a healthcare provider, typically based on weight and specific condition.
-Hypersensitivity to mesalazine or any component of the formulation -Severe renal impairment -Active gastrointestinal bleeding
-Use with caution in patients with renal or hepatic impairment -Monitor renal function periodically during treatment -Caution in patients with a history of gastrointestinal obstruction or perforation
-Common: Nausea, vomiting, abdominal pain, headache, diarrhea -Serious: Renal impairment, allergic reactions, liver enzyme abnormalities, blood dyscrasias
-Potential interactions with anticoagulants and other medications affecting renal function -May affect the absorption of other drugs, such as azathioprine
Brand Name | Manufactured by |
---|---|
ELMES | ELDER PHARMACEUTICALS LTD. |
MESACOL ENEMA | Sun Pharmaceutical Industries Ltd. |
TIDOCOL | TORRENT LABS (P) LTD. |